PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 25, 2026Pediatric Radiology0 citationsOpen Access

Multiparametric MRI biomarkers in pediatric osteosarcoma: associations of ADC, necrosis, and tumor volume with histologic and clinical outcomes in a retrospective cohort study

ICIsabela Azevedo Nicodemos da CruzLFLaura M. FayadCMCarla Renata Pacheco Donato Macedo

Key Points

  • To evaluate the associations between quantitative MRI features and histologic and clinical outcomes in pediatric osteosarcoma.
  • Retrospective cohort study of 50 pediatric patients with confirmed osteosarcoma from 2014 to 2023.
  • MRI with diffusion-weighted imaging was performed at diagnosis and after neoadjuvant chemotherapy.
  • Associations between imaging parameters and outcomes were evaluated using nonparametric and time-to-event analyses.
  • Pre-treatment ADC minimum differed significantly between good and poor histologic responders (P =0.047).
  • Post-treatment tumor volume was significantly associated with clinical outcomes (P =0.005).
  • Pre-treatment ADC minimum was associated with overall survival (ρ =−0.300, P =0.038) and post-treatment ADC minimum with disease-free survival (ρ =−0.458, P =0.028).

Abstract

Abstract Background Assessment of response to neoadjuvant chemotherapy in pediatric osteosarcoma is challenging, as histologic evaluation of tumor necrosis is only available after surgical resection. Quantitative MRI parameters, including diffusion-weighted imaging (DWI)–derived apparent diffusion coefficient (ADC) values, tumor volume, and radiologic necrosis, may provide noninvasive information related to treatment response and outcomes. Objective To evaluate quantitative MRI features before and after neoadjuvant chemotherapy in pediatric osteosarcoma and to investigate their associations with histologic response and clinical outcomes. Materials and methods This retrospective single-center cohort study included 50 pediatric patients with histologically confirmed osteosarcoma (2014–2023) who underwent MRI with DWI at diagnosis and after neoadjuvant chemotherapy. Tumor volume, radiologic necrosis, and ADC parameters (minimum, mean, and maximum) were independently assessed by two musculoskeletal radiologists. Histologic response was graded using the Huvos system. Associations between imaging parameters and histologic response, survival outcomes, and relapse were evaluated using nonparametric and exploratory time-to-event analyses. Results Fifty pediatric patients were included (mean age 13.2 years; 62% male), of whom 21% had metastatic disease at diagnosis. Pre-treatment ADC minimum differed between good and poor histologic responders (median 661.75 vs 851.0×10⁻⁶ mm 2 /s; P =0.047). Tumor volume variation showed evidence of association with Huvos grade (Spearman ρ =−0.402, P =0.004). Post-treatment tumor volume was associated with clinical outcome ( P =0.005), and larger pre- and post-treatment volumes were observed in patients who relapsed. All ADC parameters increased after chemotherapy ( P <0.01). Pre-treatment ADC minimum showed evidence of association with overall survival ( ρ =−0.300, P =0.038), while post-treatment ADC minimum was associated with disease-free survival ( ρ =−0.458, P =0.028). ROC analysis of pre-treatment ADC minimum yielded an AUC of 0.68 for histologic response. Conclusion Quantitative MRI parameters demonstrate exploratory associations with histologic response and clinical outcomes in pediatric osteosarcoma, providing additional information when interpreted alongside conventional MRI features and clinical data.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Cruz et al. (2026) studied this question.

synapsesocial.com/papers/6a13e83b0e02ee3982d32e77https://doi.org/10.1007/s00247-026-06665-4
Ask AI
Helpful
Bookmark
Share
View Full Paper